Cargando…
Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus
BACKGROUND: Increased serum autoantibodies against interleukin-2 (anti-IL-2 autoantibodies) were reported in patients with systemic lupus erythematosus (SLE) and in patients receiving IL-2 therapy. This study aimed to explore the clinical relevance of serum anti-IL-2 autoantibodies and the interacti...
Autores principales: | Shao, Miao, Sun, Xiao-Lin, Sun, He, He, Jing, Zhang, Rui-Jun, Zhang, Xia, Li, Zhan-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032677/ https://www.ncbi.nlm.nih.gov/pubmed/29941704 http://dx.doi.org/10.4103/0366-6999.235114 |
Ejemplares similares
-
Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
por: Pan, Qingjun, et al.
Publicado: (2017) -
Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus
por: Nehring, Josephine, et al.
Publicado: (2018) -
Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
Publicado: (1991) -
Features of hyperintense white matter lesions and clinical relevance in systemic lupus erythematosus
por: Guo, Qian, et al.
Publicado: (2022) -
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
por: Zhang, Xia, et al.
Publicado: (2021)